1. Canadian Agency for Drugs and Technologies in Health. Guidelines for the economic evaluation of health technologies: Canada (4th ed.). Ottawa: Canadian Agency for Drugs and Technologies in Health. 2017. https://www.cadth.ca/sites/default/files/pdf/guidelines_for_the_economic_evaluation_of_health_technologies_canada_4th_ed.pdf. Accessed 6 Aug 2020.
2. National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. London: National Institute for Health and Care Excellence. 2013. https://www.nice.org.uk/process/pmg9/resources/guide-to-the-methods-of-technology-appraisal-2013-pdf-2007975843781. Accessed 6 Aug 2020.
3. Pharmaceutical Benefits Advisory Committee. Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (Version 5.0). Canberra: Pharmaceutical Benefits Advisory Committee. 2016. https://pbac.pbs.gov.au/content/information/files/pbac-guidelines-version-5.pdf. Accessed 6 Aug 2020.
4. Brouwer WBF, Culyer AJ, van Exel NJA, Rutten FFH. Welfarism vs. extra-welfarism. J Health Econ. 2008;27(2):325–38.
5. Coast J, Smith R, Lorgelly P. Should the capability approach be applied in Health Economics? Health Econ. 2008;17(6):667–70.